Overview
NVNO market data
Price History
NVNO price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.29 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.24 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -5,483.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.67 – $178.15 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $7M · P/B 0.24 · P/S 38.88.
Company News
enVVeno Announces Publication Of Peer-Reviewed Health Economics Study Supporting Venous Valve Therapy; Findings May Support Future Coverage And Reimbursement DecisionsBenzinga · Aug 4, 2026, 12:49 PM
enVVeno Medical Says Peer-Reviewed Study Projects More Than $32K In Healthcare Savings Per Patient Over Five Years From Venous Valve Replacement TherapyBenzinga · Aug 4, 2026, 12:48 PM
enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoYBenzinga · Jul 31, 2026, 12:58 PM
enVVeno Medical Says It Received FDA IDE Approval For TAVVE Pivotal Study Of enVVe Replacement Venous Valve, Enrollment Of Approximately 230 Patients Expected To Begin In H2 2026Benzinga · Jul 31, 2026, 12:35 PM
enVVeno Medical Highlights Recently-Announced U.S. Patent For enVVe System For Non-Surgical Replacement Venous ValvesBenzinga · Jul 15, 2026, 12:34 PM
8-K filing — enVVeno Medical Corp (NVNO)SEC EDGAR · Jul 14, 2026, 8:55 PM
EnVVeno Medical Issued U.S. Patent For Its Intellectual Property Portfolio Supporting Its enVVe Transcatheter Replacement Venous Valve System To Treat Venous DiseaseBenzinga · Jul 7, 2026, 12:35 PM